Journal of Comparative Effectiveness Research

Papers
(The TQCC of Journal of Comparative Effectiveness Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA107
The economic cost of racial disparities in patients undergoing cardiac valve repair or replacement88
Does off-hours endoscopic hemostasis affect outcomes of nonvariceal upper gastrointestinal bleeding?43
Letter in reply39
Corrigendum38
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis33
The views of teenagers with obesity, their caregivers, and doctors: a plain language summary of the ACTION Teens global survey27
Journal of Comparative Effectiveness Research : 2022 year in review23
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 1022
Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study22
Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database22
A plain language summary of the long-term relugolix combination therapy study for uterine fibroids21
Systematic literature review of evidence in amyloid light-chain amyloidosis20
Meta-analysis of visual pretreatment for the prevention of emergence delirium in children undergoing ophthalmic surgery19
Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals17
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making17
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer17
Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study17
Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics16
Use of interrupted time-series analyses in evaluating health economic outcomes following implementation of multilayer water-tight wound closure in a primary total joint arthroplasty population16
Patterns and association of vaccination among adults with a history of cancer in the USA: a population-based study15
Screening for diminished ovarian reserve in Portugal: a cost-saving answer to shorten the fertility journey15
An observational cohort study of pelvic floor photobiomodulation for treatment of chronic pelvic pain15
Protocol for the implementation of a statewide mobile addiction program14
Improved estimation of overall survival and progression-free survival for state transition modeling14
The health-related quality of life of patients with a benign gynecological condition: a 2-year follow-up14
Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis13
Corrigendum12
Burden of illness for patients with primary biliary cholangitis: an observational study of clinical characteristics and healthcare resource utilization12
Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas that can't be removed by surgery, and impact on how the condition affects caregivers: a plain language summary12
The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries12
Evaluation of reporting in time-driven activity-based costing studies on cardiovascular diseases: a scoping review12
Access in all areas? A round up of developments in market access and health technology assessment: part 312
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 1812
Corrigendum12
Trends in adoption of knotless tissue control devices in robotic surgery11
Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis10
US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior10
Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis10
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations10
What works when: mapping patient and stakeholder engagement methods along the ten-step continuum framework10
Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depression10
Uricemia in the acute phase of myocardial infarction and its relation to long-term mortality risk9
Postoperative outcomes and anesthesia type in total knee arthroplasty in patients with obstructive sleep apnea9
The cost–effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark9
Impact analysis of expanding anti-TNF therapy for Crohn’s disease9
Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis9
Design and methods of a tailored approach for diabetes prevention in women with previous gestational diabetes9
An impact evaluation of an education bundle for patients at risk of developing venous thromboembolism9
Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma9
Cost–effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes8
Engaging veterans in the research process: a practical guide8
Effects of 12-week Pilates training program on cardiac autonomic modulation: a randomized controlled clinical trial8
Health technology assessments and real-world evidence: tell us what you want, what you really, really want8
Reducing length of antibiotics for children with ear infections: protocol for a cluster-randomized trial in the USA7
Cost–effectiveness of pembrolizumab for second-line treatment of esophageal squamous cell carcinoma patients with a combined positive score of 10 or more7
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 127
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA7
A clinical decision support tool for metabolic dysfunction-associated steatohepatitis in real-world clinical settings: a mixed-method implementation research study protocol7
Corrigendum7
Teclistamab versus real-world physician’s choice of therapy in triple-class exposed relapsed/refractory multiple myeloma7
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers7
Patterns of emergency department visits preceding colorectal cancer diagnosis: a population-based study7
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy7
Regional differences in the utilization and outcomes of cerebral embolic protection during transcatheter aortic valve replacement: an analysis of the National Inpatient Sample from 2017 through 20196
A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications6
Navigating adalimumab biosimilars: an expert opinion6
RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 166
Are treatment effects consistent with hypothesized mechanisms of action proposed for postoperative delirium interventions? Reanalysis of systematic reviews6
Cost–effectiveness analysis of a resource-intensive approach versus minimally invasive strategy for high-risk transcatheter aortic valve replacement patients6
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design6
Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements6
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy6
The impact of a patient advisory board on a clinical comparative effectiveness trial: a comparison of patient and researcher perspectives6
Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary6
Distinguishing cardiac catheter ablation energy modalities by applying natural language processing to electronic health records6
Current practice of stakeholder engagement: researchers’ experiences in North America, DACH countries and China6
Acute effects of resistance exercise with blood flow restriction on cardiovascular response: a meta-analysis6
Novel and existing flexible survival methods for network meta-analyses6
Efficacy classification of modern therapies in multiple sclerosis6
Redesign of radiotherapy for prostate cancer: a proposal for universal healthcare systems6
Cost–effectiveness of concurrent radiation with cetuximab or chemotherapy in older patients with oropharyngeal cancer6
Effectiveness and safety of asfotase alfa for people with hypophosphatasia: a plain language summary of three studies5
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic NTRK gene fusion cancers5
Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?5
Cost–effectiveness of ensartinib for patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer in China5
Missing data methods for intensive care unit SOFA scores in electronic health records studies: results from a Monte Carlo simulation5
An investigation to choose the proper therapy technique in the management of autism spectrum disorder5
Treatment goals for rheumatoid arthritis: patient engagement and goal collection5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 75
Discharges against medical advice and 30-day healthcare costs: an analysis of commercially insured adults5
Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary5
Cost–effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China5
Institute for Clinical and Economic Review – Peterson Health Technology Institute value assessment framework for digital health technologies5
Comparing prospectively assigned trial and real-world lung cancer patients5
Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma4
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 84
Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age4
A real world cost-minimization analysis comparing the use of different endoscopic staplers in video-assisted thoracic surgery lobectomy procedures4
Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment c4
Expanding the learning health system model to be health literate4
The impact of lower limb chronic venous disease on quality of life: patient and physician perspectives4
An economic evaluation of teledermatology care delivery for chronic skin diseases4
Impact of clinical research coordinators on research output in orthopedic surgery4
A clinical systematic literature review of treatments among patients with advanced and/or metastatic human epidermal growth factor receptor 2 positive breast cancer4
Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis4
Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome4
Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses4
Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis4
MASTRO I: Meta-Analysis and Systematic Review of thrombectomy stent retriever outcomes: comparing functional, safety and recanalization outcomes between EmboTrap, Solitaire and Trevo in acute ischemic4
Promoting community stakeholder engagement in research on treatment for pregnant women with opioid use disorder4
Comparative effectiveness of glasdegib versus venetoclax combined with low-dose cytarabine in acute myeloid leukemia4
Cost standard set program: moving forward to standardization of cost assessment based on clinical condition4
Matching-adjusted indirect comparison via a polynomial-based non-linear optimization method4
Indirect treatment comparison of olaparib and talazoparib in germline BRCA-mutated HER2-negative metastatic breast cancer4
Assessing the change in disease severity based on depressive symptoms in real-world psoriasis patients4
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study4
Corrigendum4
Visualizing the randomized sham-controlled trial in orthopedic research: proposed steps to conducting a total knee arthroplasty randomized controlled trial4
White bagging, brown bagging and site of service policies: best practices in addressing provider markup in the commercial insurance market4
A value-based budget impact model for dronedarone compared with other rhythm control strategies4
A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer4
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy4
Access in all areas? a round up of developments in market access and health technology assessment: part 44
An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD4
Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value4
0.22011995315552